
Sign up to save your podcasts
Or
Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India
3.5
1212 ratings
Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis, the youngest amongst his pharma peers at 47, a trained doctor who has come up the ranks from R&D. Balachandran delves into our latest cover story which dissects Novartis' play in India
7,902 Listeners
538 Listeners
286 Listeners
402 Listeners
1,121 Listeners
15 Listeners
55 Listeners
90 Listeners
37 Listeners
41 Listeners
5 Listeners
15 Listeners
87 Listeners
10 Listeners
16 Listeners